Venrock is one of the oldest and most established venture capital firms in the world, originally founded in 1969 as the venture capital arm of the Rockefeller family. With a legacy spanning over five decades, Venrock has consistently backed entrepreneurs who are building disruptive and transformative companies. The firm primarily focuses on early-stage investments in two core sectors: technology (including enterprise software, cloud infrastructure, AI, cybersecurity, and fintech) and healthcare (including biotechnology, medical devices, and digital health). Venrock is known for its deep domain expertise, long-term partnership approach, and its role in funding iconic companies such as Intel, Apple, Check Point Software, and numerous groundbreaking healthcare enterprises. They provide not just capital, but also strategic guidance, operational support, and access to an extensive network to help founders scale their businesses.
The Palo Alto office serves as the central hub for Venrock's West Coast investment activities, operational management, strategic decision-making, and engagement with entrepreneurs and portfolio companies.
The office is a modern, professional space designed for collaboration and meetings, reflecting the firm's status. Its location offers easy access to Stanford University and the dense network of tech companies and startups in the area.
Venrock's work culture is characterized by intellectual rigor, deep industry expertise, a collaborative spirit among partners, and a strong focus on supporting entrepreneurs. It fosters a long-term perspective on building impactful companies.
Being headquartered in Palo Alto is crucial for Venrock, providing unparalleled access to deal flow, talent, and the latest technological trends emerging from Silicon Valley. It underscores their commitment to being at the forefront of innovation.
While Venrock's primary investment focus is on companies based in the United States, particularly in technology and healthcare hubs, it actively supports its portfolio companies in their global expansion strategies. The firm leverages its extensive international network and experience to help entrepreneurs access new markets, build global teams, and establish worldwide leadership for their innovations.
530 Lytton Avenue, Suite 300
Palo Alto
CA
USA
Address: 7 Bryant Park, 22nd Floor, New York, NY 10018
To provide a strong presence on the East Coast, facilitating investments, portfolio company support, and networking within the region's dynamic innovation landscape.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Venrock' leadership includes:
Venrock has been backed by several prominent investors over the years, including:
Venrock maintains a relatively stable partnership with a focus on long-term commitment and internal development. Major publicly announced external hires or departures at the senior partner level are infrequent. Promotions from within are more common for leadership succession.
Discover the tools Venrock uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Venrock commonly utilizes a professional email format that combines the first initial of an employee's first name with their full last name, followed by the @venrock.com domain.
[first_initial][last]@venrock.com
Format
jdoe@venrock.com
Example
90%
Success rate
Venrock Blog / PR Newswire • October 26, 2023
Venrock announced the closing of Venrock X, L.P., a $650 million fund. This new fund will enable Venrock to continue its strategy of making early-stage investments in innovative technology and healthcare companies, partnering with entrepreneurs to build transformative businesses....more
Endpoints News • July 12, 2023
Venture capital firm Venrock spotlighted three new biotech investments: Clade Therapeutics, Rapport Therapeutics, and Nariyana. These investments underscore Venrock's continued focus on backing innovative companies in the life sciences sector and leveraging its deep expertise in healthcare....more
Fierce Biotech • May 3, 2023
Venrock led a $14 million Series A financing round for Amberstone Biosciences, an emerging biotech company focused on developing RNA editing therapeutics. This investment signals Venrock's commitment to pioneering technologies in the biopharmaceutical space....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Venrock, are just a search away.